TFF
AGN

The Family Firm’s Allergan plc AGN Stock Holding History

The Family Firm’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-849
Closed -$206K – 126
2017
Q2 		$206K Buy
+849
New +$200K 0.09% 116

Other funds holding AGN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Edgewood Management
Edgewood Management Greenwich, Connecticut $15.5B AUM 9.67% 1-Year Est. Return

The Family Firm's AGN Position: Q3 2017 in Review

The Family Firm sold out of Allergan plc (AGN) in Q3 2017, closing a stake of 849 shares — an estimated $206K sold.

The Family Firm first reported a position in AGN in Q2 2017 and held it in 1 quarter. The position peaked at $206K in Q2 2017. 1,090 funds tracked by Wall St. Rank hold AGN as of Q3 2017.

  • The Family Firm reported no remaining Allergan plc position as of Q3 2017 after selling out during the quarter.
  • The Family Firm sold 849 Allergan plc shares in Q3 2017, an estimated $206K.
  • The Family Firm first reported a position in Allergan plc in Q2 2017 and held it in 1 quarter.
  • The Family Firm's Allergan plc position peaked at $206K in Q2 2017.
  • 1,090 funds tracked by Wall St. Rank held Allergan plc as of Q3 2017.

Based on The Family Firm's 13F filing for Q3 2017, filed 7 Nov 2017.